MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
about
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by NefHIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationCharacterization, mapping, and distribution of the two XMRV parental provirusesNef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag.Murine leukemia viruses: objects and organisms.Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms.Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanismsComparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivityFunctional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.Endogenous Murine Leukemia Viruses: Relationship to XMRV and Related Sequences Detected in Human DNA Samples.The activity of Nef on HIV-1 infectivityHIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer.Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.HIV: Antiviral action countered by Nef.Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate With The Viral Envelope as a Type I Integral Membrane Protein.SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.
P2860
Q24338889-1AB0E907-2121-4B1B-BC34-AC242BE5210AQ24338895-BEC1F343-6D26-4D56-BC5F-26EDEFFE5855Q28251595-118929CD-9E4C-42CF-99E3-637D073C8521Q34109778-1CA1A174-1947-4016-BE8E-3409A4B49433Q34115576-9E20FF8D-58E5-4AE7-8EF6-CB474269A398Q34591671-9CB6ADDE-8B47-4AD6-B214-FF9E86144D90Q35692330-03385145-C456-44F0-8493-90EC4A494636Q35927461-C1AEAE25-A93A-48FF-8D70-3DA5D12625BFQ36175682-5FE047AF-6725-41F5-8C5A-22DB5551DC3EQ36759728-48EB47D3-E94A-4CDA-803C-A7B30EF31458Q36895829-B83E6D76-B829-4004-BCDE-C8F27A5F553BQ37396102-FE60A0C8-255E-4756-B35B-DB4D9C3E6742Q37430541-A64539B4-7288-49B0-9579-70EC6B4B53AAQ37469506-B4A64EE7-5517-49EC-87A6-2AEE063D9E7DQ37643789-8A09F53A-1D8E-4BDB-A5E9-914146A55533Q37959034-CE01B48F-BF51-439D-80BE-A7485947FBBDQ37982060-EF15D66F-DBE2-46EB-9D40-FB81EE5C5F15Q38218107-B12922AA-27FF-4122-A031-1A40F6221A69Q39118089-92AB5048-A09B-41CB-A71F-170D4A05A9F9Q39668496-4D1D4764-0D71-4BBD-9E87-C7C51F20E244Q40301185-7105B2F3-2E84-4274-9DEA-75546CA39A9BQ40580241-AEE0C67E-F211-4AF2-8C88-86F7AEE4F675Q40857639-E0CB417B-1B2B-4214-AC4D-F4E6169FE2CFQ41293252-3244A94C-91FC-4653-AC1A-70E1822F6429Q47234345-E959CDF7-89B4-475B-B18B-E0971ED2E45FQ47550082-4EAD5F07-5603-4583-9868-DC050A9A13B9Q47550785-A41BBC62-3911-47A6-B06C-D8DFC8803FFD
P2860
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@ast
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@en
type
label
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@ast
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@en
prefLabel
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@ast
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@en
P2860
P356
P1476
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.
@en
P2093
Massimo Pizzato
P2860
P304
P356
10.1073/PNAS.1001554107
P407
P577
2010-05-03T00:00:00Z